ea0014p533 | (1) | ECE2007
Barahona Maria-Jose
, Sucunza Nuria
, Lluch Pilar
, Fedrnandez-Real Jose-Manuel
, Ricart Wifredo
, Puig Teresa
, Wäger Ana M
, van Elzelingen Caroline
, Farrerons Jordi
, Webb Susan M
High dose and long-term glucocorticoid (GC) therapy reduce bone mass and negatively affect the metabolic profile. Patients in remission after successful treatment of Cushings syndrome (CS) often present hypoadrenalism and require long-term GC replacement.Objective: To evaluate the effect of GC therapy on bone and metabolic parameters in women after long-term remission of CS. Materials and methods: Thirty-two women (mean age: 50±14 years) with ...